TrianglePUBLICATIONS · 37883081
Sustained Survival Benefit in Recurrent Medulloblastoma by a Metronomic Antiangiogenic Regimen: A Nonrandomized Controlled Trial.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- JAMA Oncol
- Publication date
- 2023 Dec 1
- First author
- Peyrl A
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Peyrl A
- type
- Author
- name
- Chocholous M
- type
- Author
- name
- Sabel M
- type
- Author
- name
- Lassaletta A
- type
- Author
- name
- Sterba J
- type
- Author
- name
- Leblond P
- type
- Author
- name
- Nysom K
- type
- Author
- name
- Torsvik I
- type
- Author
- name
- Chi SN
- type
- Author
- name
- Perwein T
- type
- Author
- name
- Jones N
- type
- Author
- name
- Holm S
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Peyrl A
- type
- Author
- name
- Chocholous M
- type
- Author
- name
- Sabel M
- type
- Author
- name
- Lassaletta A
- type
- Author
- name
- Sterba J
- type
- Author
- name
- Leblond P
- type
- Author
- name
- Nysom K
- type
- Author
- name
- Torsvik I
- type
- Author
- name
- Chi SN
- type
- Author
- name
- Perwein T
- type
- Author
- name
- Jones N
- type
- Author
- name
- Holm S
- type
- Author
- bibliography ids
- nci-bib-8a6a867ac98813b47a9d96c4
- book metadata
- content sha256
- 20ad916f063ca314952f8afcbf13cbfd3a9b3ee3fa53bd87c2cbc7f174dd338c
- document type
- citation
- dois
- 10.1001/jamaoncol.2023.4437
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:37883081
- immutable id
- pubmed:37883081@20ad916f063ca314952f8afcbf13cbfd3a9b3ee3fa53bd87c2cbc7f174dd338c
- journal
- abbreviation
- JAMA Oncol
- issn electronic
- 2374-2445
- issn print
- 2374-2437
- issue
- 12
- name
- JAMA oncology
- nlm unique id
- 101652861
- pages
- 1688-1695
- volume
- 9
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 37883081
- provenance
- batch id
- 6d213eecf21b6b7867cb
- provider
- NCBI PubMed ESummary
- record sha256
- 6824f5305a952eee7b315c9e18fd283c98579b4dd472452abed34084c94b6486
- response sha256
- 684f894a21d8f5f78a3bd0acd8ee4215ff94144487c53dab1056650ee8d6751d
- retrieved at
- 2026-09-09T23:48:19.049083+00:00
- publication date
- display
- 2023 Dec 1
- precision
- day
- year
- 2023
- publication types
- Controlled Clinical Trial
- Multicenter Study
- Journal Article
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Sustained Survival Benefit in Recurrent Medulloblastoma by a Metronomic Antiangiogenic Regimen: A Nonrandomized Controlled Trial.
Preserved source evidence · Not medical advice